West Pharmaceutical Services (WST) Asset Utilization Ratio (2010 - 2026)

West Pharmaceutical Services has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.81 in Q2 2026.

• Quarterly Asset Utilization Ratio rose 3.94% year-over-year to 0.81 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.81 (up 3.94% YoY) and the FY2025 annual result came in at 0.78, changed 0.34% from the prior year.
• Asset Utilization Ratio improved to 0.81 in Q2 2026 per WST's latest filing, from 0.77 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.88 in Q2 2022 and troughed at 0.73 in Q4 2025.
• A 5-year average of 0.8 and a median of 0.79 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio slipped 11.89% in 2023, then advanced 4.65% in 2024.
• Over 5 years, Asset Utilization Ratio stood at 0.83 in 2022, then slipped by 6.59% to 0.78 in 2023, then advanced by 1.64% to 0.79 in 2024, then dropped by 7.16% to 0.73 in 2025, then climbed by 10.73% to 0.81 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.81, 0.77, and 0.73 for Q2 2026, Q1 2026, and Q4 2025 respectively.